Global Probenecid Tablets Market Growth 2024-2030

Publication ID:

LPI09244819

Publication Date:

September 27, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Probenecid tablets are pharmaceuticals primarily prescribed for chronic gout and gouty arthritis.Operating as a uricosuric agent,they function by inhibiting uric acid reabsorption in the kidney tubules,thereby increasing its excretion through urine and reducing blood uric acid levels.Beyond gout treatment,Probenecid tablets are sometimes used to enhance the effectiveness of antibiotics by inhibiting their renal excretion.
The global Probenecid Tablets market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淧robenecid Tablets Industry Forecast鈥� looks at past sales and reviews total world Probenecid Tablets sales in 2023, providing a comprehensive analysis by region and market sector of projected Probenecid Tablets sales for 2024 through 2030. With Probenecid Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Probenecid Tablets industry.
This Insight Report provides a comprehensive analysis of the global Probenecid Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Probenecid Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Probenecid Tablets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Probenecid Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Probenecid Tablets.
United States market for Probenecid Tablets is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Probenecid Tablets is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Probenecid Tablets is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Probenecid Tablets players cover Lannett Company, Teva, Rising Pharma, Watson Pharmaceuticals, Geno Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Probenecid Tablets market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
0.25g per Tablet
0.50g per Tablet
Segmentation by Application:
Hospitals and Clinics
Retail Pharmacies
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Lannett Company
Teva
Rising Pharma
Watson Pharmaceuticals
Geno Pharmaceuticals
Salvavidas Pharmaceutical
Sunflower Pharmaceutical Group
Jinling Pharmaceutical
Shanghai Sine Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Probenecid Tablets market?
What factors are driving Probenecid Tablets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Probenecid Tablets market opportunities vary by end market size?
How does Probenecid Tablets break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Probenecid Tablets Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Probenecid Tablets by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Probenecid Tablets by Country/Region, 2019, 2023 & 2030
2.2 Probenecid Tablets Segment by Type
2.2.1 0.25g per Tablet
2.2.2 0.50g per Tablet
2.3 Probenecid Tablets Sales by Type
2.3.1 Global Probenecid Tablets Sales Market Share by Type (2019-2024)
2.3.2 Global Probenecid Tablets Revenue and Market Share by Type (2019-2024)
2.3.3 Global Probenecid Tablets Sale Price by Type (2019-2024)
2.4 Probenecid Tablets Segment by Application
2.4.1 Hospitals and Clinics
2.4.2 Retail Pharmacies
2.4.3 Other
2.5 Probenecid Tablets Sales by Application
2.5.1 Global Probenecid Tablets Sale Market Share by Application (2019-2024)
2.5.2 Global Probenecid Tablets Revenue and Market Share by Application (2019-2024)
2.5.3 Global Probenecid Tablets Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global Probenecid Tablets Breakdown Data by Company
3.1.1 Global Probenecid Tablets Annual Sales by Company (2019-2024)
3.1.2 Global Probenecid Tablets Sales Market Share by Company (2019-2024)
3.2 Global Probenecid Tablets Annual Revenue by Company (2019-2024)
3.2.1 Global Probenecid Tablets Revenue by Company (2019-2024)
3.2.2 Global Probenecid Tablets Revenue Market Share by Company (2019-2024)
3.3 Global Probenecid Tablets Sale Price by Company
3.4 Key Manufacturers Probenecid Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Probenecid Tablets Product Location Distribution
3.4.2 Players Probenecid Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Probenecid Tablets by Geographic Region
4.1 World Historic Probenecid Tablets Market Size by Geographic Region (2019-2024)
4.1.1 Global Probenecid Tablets Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Probenecid Tablets Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Probenecid Tablets Market Size by Country/Region (2019-2024)
4.2.1 Global Probenecid Tablets Annual Sales by Country/Region (2019-2024)
4.2.2 Global Probenecid Tablets Annual Revenue by Country/Region (2019-2024)
4.3 Americas Probenecid Tablets Sales Growth
4.4 APAC Probenecid Tablets Sales Growth
4.5 Europe Probenecid Tablets Sales Growth
4.6 Middle East & Africa Probenecid Tablets Sales Growth
5 Americas
5.1 Americas Probenecid Tablets Sales by Country
5.1.1 Americas Probenecid Tablets Sales by Country (2019-2024)
5.1.2 Americas Probenecid Tablets Revenue by Country (2019-2024)
5.2 Americas Probenecid Tablets Sales by Type (2019-2024)
5.3 Americas Probenecid Tablets Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Probenecid Tablets Sales by Region
6.1.1 APAC Probenecid Tablets Sales by Region (2019-2024)
6.1.2 APAC Probenecid Tablets Revenue by Region (2019-2024)
6.2 APAC Probenecid Tablets Sales by Type (2019-2024)
6.3 APAC Probenecid Tablets Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Probenecid Tablets by Country
7.1.1 Europe Probenecid Tablets Sales by Country (2019-2024)
7.1.2 Europe Probenecid Tablets Revenue by Country (2019-2024)
7.2 Europe Probenecid Tablets Sales by Type (2019-2024)
7.3 Europe Probenecid Tablets Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Probenecid Tablets by Country
8.1.1 Middle East & Africa Probenecid Tablets Sales by Country (2019-2024)
8.1.2 Middle East & Africa Probenecid Tablets Revenue by Country (2019-2024)
8.2 Middle East & Africa Probenecid Tablets Sales by Type (2019-2024)
8.3 Middle East & Africa Probenecid Tablets Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Probenecid Tablets
10.3 Manufacturing Process Analysis of Probenecid Tablets
10.4 Industry Chain Structure of Probenecid Tablets
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Probenecid Tablets Distributors
11.3 Probenecid Tablets Customer
12 World Forecast Review for Probenecid Tablets by Geographic Region
12.1 Global Probenecid Tablets Market Size Forecast by Region
12.1.1 Global Probenecid Tablets Forecast by Region (2025-2030)
12.1.2 Global Probenecid Tablets Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Probenecid Tablets Forecast by Type (2025-2030)
12.7 Global Probenecid Tablets Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 Lannett Company
13.1.1 Lannett Company Company Information
13.1.2 Lannett Company Probenecid Tablets Product Portfolios and Specifications
13.1.3 Lannett Company Probenecid Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Lannett Company Main Business Overview
13.1.5 Lannett Company Latest Developments
13.2 Teva
13.2.1 Teva Company Information
13.2.2 Teva Probenecid Tablets Product Portfolios and Specifications
13.2.3 Teva Probenecid Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Teva Main Business Overview
13.2.5 Teva Latest Developments
13.3 Rising Pharma
13.3.1 Rising Pharma Company Information
13.3.2 Rising Pharma Probenecid Tablets Product Portfolios and Specifications
13.3.3 Rising Pharma Probenecid Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Rising Pharma Main Business Overview
13.3.5 Rising Pharma Latest Developments
13.4 Watson Pharmaceuticals
13.4.1 Watson Pharmaceuticals Company Information
13.4.2 Watson Pharmaceuticals Probenecid Tablets Product Portfolios and Specifications
13.4.3 Watson Pharmaceuticals Probenecid Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Watson Pharmaceuticals Main Business Overview
13.4.5 Watson Pharmaceuticals Latest Developments
13.5 Geno Pharmaceuticals
13.5.1 Geno Pharmaceuticals Company Information
13.5.2 Geno Pharmaceuticals Probenecid Tablets Product Portfolios and Specifications
13.5.3 Geno Pharmaceuticals Probenecid Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Geno Pharmaceuticals Main Business Overview
13.5.5 Geno Pharmaceuticals Latest Developments
13.6 Salvavidas Pharmaceutical
13.6.1 Salvavidas Pharmaceutical Company Information
13.6.2 Salvavidas Pharmaceutical Probenecid Tablets Product Portfolios and Specifications
13.6.3 Salvavidas Pharmaceutical Probenecid Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Salvavidas Pharmaceutical Main Business Overview
13.6.5 Salvavidas Pharmaceutical Latest Developments
13.7 Sunflower Pharmaceutical Group
13.7.1 Sunflower Pharmaceutical Group Company Information
13.7.2 Sunflower Pharmaceutical Group Probenecid Tablets Product Portfolios and Specifications
13.7.3 Sunflower Pharmaceutical Group Probenecid Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Sunflower Pharmaceutical Group Main Business Overview
13.7.5 Sunflower Pharmaceutical Group Latest Developments
13.8 Jinling Pharmaceutical
13.8.1 Jinling Pharmaceutical Company Information
13.8.2 Jinling Pharmaceutical Probenecid Tablets Product Portfolios and Specifications
13.8.3 Jinling Pharmaceutical Probenecid Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Jinling Pharmaceutical Main Business Overview
13.8.5 Jinling Pharmaceutical Latest Developments
13.9 Shanghai Sine Pharmaceutical
13.9.1 Shanghai Sine Pharmaceutical Company Information
13.9.2 Shanghai Sine Pharmaceutical Probenecid Tablets Product Portfolios and Specifications
13.9.3 Shanghai Sine Pharmaceutical Probenecid Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Shanghai Sine Pharmaceutical Main Business Overview
13.9.5 Shanghai Sine Pharmaceutical Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂